On March 24, the Jiangsu Provincial Government and AstraZeneca signed a strategic cooperation framework agreement in Nanjing. Governor Xu Kunlin met with AstraZeneca's Global CEO Pascal Soriot and his team, and witnessed the signing ceremony. Xu Kunlin expressed his hope that AstraZeneca would fully leverage Jiangsu's industrial advantages, policy opportunities, and research capabilities to strengthen the integration of industry chains, supply chains, innovation chains, and talent chains. He encouraged deepening cooperation in international development, R&D innovation, investment in production, park construction, and social value creation, promoting the establishment of a biopharmaceutical industry hub with international influence.

